Atria Wealth Solutions Inc. Increases Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Atria Wealth Solutions Inc. lifted its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 28.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,256 shares of the company’s stock after buying an additional 946 shares during the quarter. Atria Wealth Solutions Inc.’s holdings in HCA Healthcare were worth $1,277,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of HCA. Integrated Advisors Network LLC lifted its stake in shares of HCA Healthcare by 0.6% in the third quarter. Integrated Advisors Network LLC now owns 5,132 shares of the company’s stock valued at $2,086,000 after purchasing an additional 31 shares during the period. First Horizon Advisors Inc. grew its holdings in shares of HCA Healthcare by 2.4% in the 3rd quarter. First Horizon Advisors Inc. now owns 1,532 shares of the company’s stock worth $623,000 after acquiring an additional 36 shares during the period. Mediolanum International Funds Ltd raised its holdings in HCA Healthcare by 0.3% during the fourth quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company’s stock worth $3,153,000 after purchasing an additional 36 shares during the last quarter. Hartford Funds Management Co LLC grew its holdings in HCA Healthcare by 1.6% in the third quarter. Hartford Funds Management Co LLC now owns 2,469 shares of the company’s stock valued at $1,003,000 after purchasing an additional 39 shares during the last quarter. Finally, Prairie Wealth Advisors Inc. boosted its position in shares of HCA Healthcare by 6.1% in the 4th quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company’s stock worth $210,000 after buying an additional 40 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analyst Ratings Changes

Several brokerages have issued reports on HCA. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $380.00 price target on shares of HCA Healthcare in a report on Tuesday, December 17th. StockNews.com downgraded HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Bank of America decreased their price objective on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a research note on Monday, January 27th. Raymond James cut shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd. Finally, Truist Financial reduced their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $385.67.

HCA Healthcare Stock Performance

NYSE HCA opened at $316.07 on Monday. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The business’s 50-day simple moving average is $313.53 and its 200-day simple moving average is $350.82. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The firm has a market capitalization of $78.49 billion, a P/E ratio of 14.39, a P/E/G ratio of 1.10 and a beta of 1.64.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the prior year, the firm posted $5.90 EPS. Equities analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be given a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.91%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. HCA Healthcare’s dividend payout ratio is presently 13.11%.

Insider Buying and Selling

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the firm’s stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the sale, the senior vice president now owns 15,412 shares in the company, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.60% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.